← Browse by Condition

Medical Condition

hematologic malignancy

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 2, EARLY_Phase 1, Phase 1

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Duke University

NCT05529069 Phase 2

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

M.D. Anderson Cancer Center

Prospective Validation of the OHI Index

Meir Medical Center

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Children's Hospital Medical Ce...

NCT05707325 EARLY_Phase 1

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies

Westlake Therapeutics

NCT07052370 Phase 1

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research H...

NCT05943067 Phase 1, Phase 2

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

University Hospital Tuebingen

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Northside Hospital, Inc.

Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Odense University Hospital

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

Wake Forest University Health ...